Given the heterogeneity of current literature and defintion of disease on this topic, a systematic review helps to get a clear picture of the current state of knowledge.
Apart from the definition for ACOS used in the systematic review, the authors might ask themselves if a golden standard realy is a golden standard, given the heterogeneity of definitions used worldwide (see also, Bonten TN et al , ERJ 2017, PMID: 28461292) . Their choice for the Spanish reference standard might bring up questions from reviewers in other countries with different standards for ACOS later in the review process. I would advice to discuss this point in a future discussion of the paper.
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GENERAL COMMENTS
The Authors presented a protocol of an interesting systematic review that aims to identify validated case-finding algorithms for asthma-COPD overlap (ACO) based on healthcare databases. The results of the planned systematic review will inform patient selection in ACO studies.
I have the following comments.
1. The following title would better reflect the text: "Validated methods to identify asthma-COPD overlap patients in healthcare databases: a systematic review protocol"
2. The introduction is almost half of the text and could be significantly shortened (e.g., the sentence "There is no cure for asthma-COPD overlap" is not needed) so that the reader gets more directly to the point of this protocol. The Introduction should include a clearer (and brief) articulation of the study motivation and importance: e.g., why validating ACO algorithms is important, what are the challenges of validation, why researchers need to know about validated ACO algorithms, and how the results of this systematic review will inform ACO research.
3. In the inclusion criteria, I understand that this systematic review will include studies that (a) used algorithms to identify ACO patients from healthcare databases, AND (b) performed validation for those algorithms. The literature search strategy included three components but it is not clear to me how they are related (with AND or OR operators). A simple diagram will be useful. If the Authors have developed/identified a search query then please report it.
4. In "Strengths and limitations of this study", the second point is not per se a strength of this study. The authors may wish to change it to "identification of properly-validated algorithms to identify patients with asthma-COPD overlap from healthcare databases will inform more accurate patient selection in future studies..."
5. In "Strengths and limitations of this study", the third point is very important but it is neither a strength nor a limitation of this study.
6. In "Strengths and limitations of this study", the fourth point is not clear enough to me. I assume the Authors mean that the systematic review will not include studies in which ACO casefinding algorithms were not accompanied by validity assessment.
7. For quality assessment of studies, the Authors may wish to also use the STARD (http://www.equator-network.org/reportingguidelines/stard/) and/or the checklist by Benchimol et al ( 10.1016 Benchimol et al ( 10. /j.jclinepi.2010 .006); these include items not covered by QUADAS.
8. The narrative could be improved at several places:
Page 2-Line 17: The expression "selection depends upon targeted validation" is unclear to me.
2-20:
The objectives based on the rest of the text could be changed to "to identify validated methods (or algorithms) that identify patients with asthma-COPD overlap from healthcare databases and summarize the reported validity measures of these methods".
2-24: "web of science" should be "Web of Science".
2-45, 11-54: What does "clinical event" mean?
4-17: A suggested re-wording: "It is possible that different algorithms to identify patients with ACO may be developed and validated in different databases, which can result …" 7-12: A suggested re-wordings: "more frequent exacerbations", "have poorer quality of life", "disproportionately large amount", "than people with asthma or COPD alone." 8-17: What does "**hierarchically** coded healthcare databases" mean?
8-33: "PPV": First use of the acronym without definition.
8-42: The Authors wrote "To determine the validity of any health outcome ..." Validity is not an attribute of a health outcome but of an algorithm used to identify (or measure, assess, etc) that health outcome from a particular data source. Therefore, I suggest rewriting this inline with: "The development of an algorithm to measure a health outcome from a particular database requires a clear understanding of data provenance and structure. The validity of an algorithm can be assessed against measures based on questionnaires …".
9-17: "Which algorithms have been extensively used to define and correctly identify patients with asthma-COPD overlap?" How would the Authors know if an algorithm *correctly* identified ACO patients where no universal gold standard exists? Unless justified, please remove the word "correctly".
9-21: A suggested re-wording: "Against which reference standards the validity of these algorithms was assessed? And what were the diagnostic accuracy estimates?
10-42: Patient-reported questionnaires as a reference standard were omitted here but were mentioned in 8-47.
10-49: I suggest replacing "and" with "or".
12-2: Please replace "gold" with "reference".
For consistency, I suggest using a hyphen in "asthma-COPD overlap" throughout the manuscript.
---END---
VERSION 1 -AUTHOR RESPONSE
Reviewer: 1
Major concerns
Major concern 1 -Quality assessment of the primary studies should be clarified. I suggest using the checklist developed by Benchimol et al, based on the criteria by the Standards for Reporting of Diagnostic accuracy (STARD) initiative for the accurate reporting of diagnostic studies (10.1016/j.jclinepi.2010.10.006; 10.1136/bmjopen-2016-011777) Response Very well noted, and thank you for this insightful suggestion. This has been addressed and subsequently revised in our manuscript. The revision is highlighted in yellow under "Risk of bias assessment".
Major concern 2 -Authors should clarify how they will analyze the data (pooled, aggregated,…)
Response
Thank you! Even though, no formal meta-analysis is planned, this has been extensively considered. Your kind suggestion has been updated and highlighted in yellow.
Major concern 3 -The search strategy should be launched after the protocol has been accepted for publication and not limited within March 2018
The launch of the search strategy has been updated in the manuscript to October 2018 when we expect our manuscript to be likely accepted for publication.
Major concern 3a -These amendments need to be reported also in the abstrac Response This has been revised and reported in the abstract as well.
Minor concerns:
Minor concern 1 -I suggest to include in the list of the data extraction (a) The type of healthcare database used (eg, electronic health record, hospitalization discharge data, etc), (b) The modality of algorithm development (eg, using logistic regression, Classification and Regression Trees, expert opinion…);
Thank you for your kind suggestions. These suggestions have been added to our list of "Data Extraction". They are highlighted in yellow. Apart from the definition for ACOS used in the systematic review, the authors might ask themselves if a golden standard realy is a golden standard, given the heterogeneity of definitions used worldwide (see also, Bonten TN et al , ERJ 2017, PMID: 28461292) . Their choice for the Spanish reference standard might bring up questions from reviewers in other countries with different standards for ACOS later in the review process. I would advice to discuss this point in a future discussion of the paper.
Thank you for your great advice. We concur that the definition of ACOS is still debatable just like asthma and COPD. In future discussions of this paper, we will take further steps to look at other definitions such as the one you did suggest.
However, your comment is reflected in the third research question. The Authors presented a protocol of an interesting systematic review that aims to identify validated case-finding algorithms for asthma-COPD overlap (ACO) based on healthcare databases. The results of the planned systematic revi3ew will inform patient selection in ACO studies.
Comment 1. The following title would better reflect the text: "Validated methods to identify asthma-COPD overlap patients in healthcare databases: a systematic review protocol"
We appreciate your kind suggestion and had some deliberations which led to changing the title to reflect what you suggested. Thank you.
Comment 2. The introduction is almost half of the text and could be significantly shortened (e.g., the sentence "There is no cure for asthma-COPD overlap" is not needed) so that the reader gets more directly to the point of this protocol. The Introduction should include a clearer (and brief) articulation of the study motivation and importance: e.g., why validating ACO algorithms is important, what are the challenges of validation, why researchers need to know about validated ACO algorithms, and how the results of this systematic review will inform ACO research.
Thank you for your kind observation. We tend to focus on validation studies on asthma-COPD overlap in particular, as its description is still unclear compared to asthma or COPD. This is intended to give a clearer picture to explain why it needs to be validated in healthcare databases. Nevertheless, the introduction has been adjusted with some sentences re-phrased (highlighted in yellow) and others removed to make the introduction succinctly clear and brief as you did suggest.
Comment 3. In the inclusion criteria, I understand that this systematic review will include studies that (a) used algorithms to identify ACO patients from healthcare databases, AND (b) performed validation for those algorithms. The literature search strategy included three components but it is not clear to me how they are related (with AND or OR operators). A simple diagram will be useful. If the Authors have developed/identified a search query then please report it.
Very well noted. A search query has been developed and added as supplementary material.
Comment 4. In "Strengths and limitations of this study", the second point is not per se a strength of this study. The authors may wish to change it to "identification of properly-validated algorithms to identify patients with asthma-COPD overlap from healthcare databases will inform more accurate patient selection in future studies..."
Thank you for your kind suggestion. This has been changed and highlighted accordingly.
Comment 5. In "Strengths and limitations of this study", the third point is very important but it is neither a strength nor a limitation of this study.
Thank you for your kind suggestion. This has been well noted. However, we felt that this particular point reflects the limitation validation imposes on generalizability. Validation studies are done based on the target database intended. The validated codes for one particular kind or type of healthcare database may not necessarily be linked to another database in a different population setting. For example, 'Read codes' for CPRD (EHR) and 'ICD codes' for databases primarily set-up for billing. This phenomenon may limit the generalizability of one algorithm validated for one kind of healthcare database to be used for a different kind of database.
Comment 6. In "Strengths and limitations of this study", the fourth point is not clear enough to me. I assume the Authors mean that the systematic review will not include studies in which ACO casefinding algorithms were not accompanied by validity assessment.
Thank you. This has been re-phrased to give a clearer understanding as highlighted in the manuscript.
Comment 7. For quality assessment of studies, the Authors may wish to also use the STARD (http://www.equator-network.org/reporting-guidelines/stard/) and/or the checklist by Benchimol et al ( 10.1016 Benchimol et al ( 10. /j.jclinepi.2010 .006); these include items not covered by QUADAS.
Thank you and as pointed out by Reviewer 1 as well, the manuscript has been revised to adopt the STARD criteria for quality assessment of studies.
Comment 8. The narrative could be improved at several places:
Thank you. For a brief of clarification, the "targeted validation" denotes the kind of database that a particular validation is intended and the parameters of algorithm definitions (e.g. Read codes for CPRD database or ICD-9/10 for Clinformatics data). Since this was the abstract section of the manuscript, we could not expantiate more.
2-20:
Response
Thank you for the kind suggestion. This has been revised to reflect your suggestion.
This has been changed and highlighted.
Thank you. Clinical event is synonymous to "clinical outcome" of a health condition or state. However, this has been revised to "clinical outcome".
4-17:
A suggested re-wording: "It is possible that different algorithms to identify patients with ACO may be developed and validated in different databases, which can result …"
Response
Thank you. This has been re-worded and highlighted under "Strengths and Limitations" 7-12: A suggested re-wordings: "more frequent exacerbations", "have poorer quality of life", "disproportionately large amount", "than people with asthma or COPD alone."
Thank you. The re-wording suggested has been revised in the manuscript accordingly.
8-17: What does "**hierarchically** coded healthcare databases" mean?
Algorithms or codes arranged in ranks or orders in healthcare databases. However, **hierarchically** has been replaced with "structured".
Thank you! This has been revised.
8-42:
The Authors wrote "To determine the validity of any health outcome ..." Validity is not an attribute of a health outcome but of an algorithm used to identify (or measure, assess, etc) that health outcome from a particular data source. Therefore, I suggest rewriting this inline with: "The development of an algorithm to measure a health outcome from a particular database requires a clear understanding of data provenance and structure. The validity of an algorithm can be assessed against measures based on questionnaires …".
Response
Thank you for the kind suggestion. This has been re-worded and highlighted in the manuscript.
The word "correctly" has been removed. 9-21: A suggested re-wording: "Against which reference standards the validity of these algorithms was assessed? And what were the diagnostic accuracy estimates?
Response Thank you. This has been re-worded.
The omission has been added.
Response "and" replaced with "or" as kindly suggested.
This has been replaced. Thank you for your suggestion.
Thank you for this and your overall suggestions. This has been done throughout the manuscript.
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